PATENT CLAIM ANALYSIS

Application Number: 16243205
Application Type: Utility
Filing Date: 2019-01
Publication Date: 2019-05
Patent Classification: ["424", "010300"]

Abstract:
The present invention relates to an abuse-proofed oral dosage form with controlled release of (1R,2R)-3-(3-dimethylamino-1-ethyl-2-methyl-propyl)phenol for once daily administration, which comprises the active ingredient and/or one or more of the pharmaceutically acceptable salts thereof (A), at least one synthetic or natural polymer (C), delayed-release auxiliary substances, optionally physiologically acceptable auxiliary substances (B) and optionally a wax (D), component (C) or (D) in each case exhibiting a breaking strength of at least 500 N, preferably of at least 1000 N.

Claim (Index 17):
A process for the production of a dosage form according to  claim 1 , comprising\n (1) mixing components (A), (C), optionally (B) and optionally (D) and optionally delayed-release matrix compounds and (2) forming the resultant mixture, optionally after pelletisation, into the dosage form by application of force and with preceding or simultaneous exposure to heat and optionally providing the dosage form with a delayed-release coating.

Metadata:
- Claim Count in Document: 38.0
- Percentile: 99.0
- Lexical Diversity: 1.56716
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['10718112', '11349544', '13270505', '15265263', '13346257']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6989970695354989
- 35 USC 102 Novelty (BERT): 0.474544269007345
- Combined Prediction Score: 0.6765517894826836
- Mean Citation Score: 186.970304
- Max Citation Score: 202.11156
- Similarity Product: 168.27549429548978

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test